Tag: RADIOENHANCER
Nanobiotix: randomization of the 1st patient in the USA in the pivotal global Phase 3 trial evaluating the radioenhancer NBTXR3 in head and neck cancer
By Jean-Baptiste André Published on 27/12/2022 at 08:41 Photo credit © Nanobiotix (Boursier.com)…
NANOBIOTIX APPOINTS LEADING EXPERTS TO FORM ITS SCIENTIFIC ADVISORY BOARD FOR NBTXR3, ITS POTENTIAL FIRST-IN-CLASS RADIOENHANCER – 02/11/2022 at 21:30
This multidisciplinary Scientific Council includes twelve (12) American and European experts contributing their expertise to the development of the main product-candidate NBTXR3Paris, France ; Cambridge, Massachusetts (USA); November 2, 2022…